https://oulurepo.oulu.fi/handle/10024/27353
Efficacy and safety of tocilizumab in a real-life observational cohort of patients with...
in areal lifeefficacysafetytocilizumab
https://c19early.org/wang47.html
Wang: Tocilizumab Ameliorates the Hypoxia in COVID-19 Moderate Patients with Bilateral Pulmonary...
Wang, 65 patient tocilizumab late treatment RCT: 27% lower progression (p=0.53), 8% longer hospitalization (p=0.35), and 6% slower viral clearance (p=0.54)......
wangtocilizumabhypoxiacovidmoderate
https://ctv.veeva.com/study/a-study-to-assess-the-effect-of-tocilizumab-plus-methotrexate-on-safety-and-signs-and-symptoms-in-pa
A Study to Assess the Effect of Tocilizumab Plus Methotrexate on Safety and Signs and Symptoms in...
This single arm, open-label study will assess the safety and efficacy with regar d to reduction of signs and symptoms of treatment with tocilizumab in...
safety and signsthe effectstudyassesstocilizumab
https://www.atuttonotizie.it/tag/tocilizumab/
tocilizumab Archivi - atuttonotizie
tocilizumabarchivi
https://www.mednet.nl/nieuws/tocilizumab-mogelijk-nuttig-refractair-takayasusyndroom/?pg=3&t=congresnieuws
Tocilizumab mogelijk nuttig bij refractair takayasusyndroom | MedNet
tocilizumabnuttigbij
https://www.protothema.gr/tag/tocilizumab/
tocilizumab
tocilizumab
https://researchconnect.stonybrook.edu/en/publications/tocilizumab-in-patients-admitted-to-hospital-with-covid-19-recove/
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled,...
in patientstocilizumabadmittedhospitalcovid
https://www.sciencetimes.com/articles/30058/20210308/tocilizumab-rheumatoid-arthritis-medication-found-reduce-severe-covid-19-deaths.htm
Tocilizumab, Rheumatoid Arthritis Medication, Found to Reduce Severe COVID-19 Deaths
Mar 8, 2021 - Clinical trials in 12 public and private hospitals in India headed by the University of Bristol and Medanta Institute of Education and Research add evidence to...
rheumatoid arthritistocilizumabmedicationfoundreduce
https://acrabstracts.org/tag/tocilizumab-and-ultrasound/
tocilizumab and ultrasound Archives - ACR Meeting Abstracts
meeting abstractstocilizumabultrasoundarchivesacr
https://www.virgilio.it/notizie/coronavirus-aifa-nessun-beneficio-tocilizumab-1398969
Coronavirus, l'Aifa annuncia: "Nessun beneficio dal Tocilizumab"
Jun 17, 2020 - L'Aifa, Agenzia Italiana del Farmaco, ha reso noto i risultati di uno studio effettuato sull'uso del Tocilizumab nella lotta al coronavirus
coronaviruslaifabeneficio
https://archivesofrheumatology.org/index.php/pub/article/view/1043/1781
View of Body Mass Index and Clinical Response to Tocilizumab in Patients With Rheumatoid Arthritis...
body mass indexrheumatoid arthritisviewclinicalresponse
https://ipkitten.blogspot.com/2018/08/birss-j-excuses-chugai-from-tocilizumab.html
Birss J excuses Chugai from tocilizumab royalties in UCB "validity tie breaker" - The IPKat
The IPKat blog reports on copyright, patent, trade mark, info-tech and confidentiality issues from a mainly UK and European perspective.
jexcusestocilizumabroyaltiesucb
https://www.jmir.org/2020/9/e21758/
Journal of Medical Internet Research - Efficacy of Hydroxychloroquine and Tocilizumab in Patients...
Background: During the initial phases of the COVID-19 pandemic, there was an unfounded fervor surrounding the use of hydroxychloroquine (HCQ) and tocilizumab...
internet researchjournalmedicalefficacyhydroxychloroquine
https://research.regionh.dk/en/publications/randomized-phase-ii-study-of-nab-paclitaxel-and-gemcitabine-with-/
Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as...
phase iistudynabpaclitaxelwithout
https://www.sifweb.org/pubblicazioni/pubblicazioni-scientifiche/pubblicazioni-scientifiche-effect-of-tocilizumab-vs-standard-care-on-clinical-worsening-in-patients-hospitalized-with-covid-19-pneumonia-a-randomized-clinical-trial-2020-10-21
Pubblicazioni scientifiche Effect of Tocilizumab vs Standard Care on Clini... | SIF
pubblicazioni scientifichestandard careeffecttocilizumabvs
https://unifind.uniss.it/resource/item/158319?language=en-US
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19...
Unifind is a portal where you can discover the expertise within a university by searching among experts, courses, professions, people, publications, and...
for patientsthe singlecorrectiontocilizumabcovid
https://www.gabionline.net/biosimilars/research/positive-phase-iii-results-for-tocilizumab-biosimilar-bat1806
Positive phase III results for tocilizumab biosimilar BAT1806
US biotechnology company Biogen Idec (Biogen) and China-based Bio-Thera announced on 1 June 2021 positive phase III data for their tocilizumab bios...
phase iiipositiveresultstocilizumabbiosimilar
https://www.iris.unicz.it/handle/20.500.12317/113075
Tocilizumab Prevents the Epileptogenesis and Psychiatric Comorbidity in WAG/Rij Rats, A Genetic...
tocilizumabpsychiatriccomorbiditywagrats
https://www.iasp-pain.org/publications/pain-research-forum/papers-of-the-week/paper/update-on-tocilizumab-in-rheumatoid-arthritis-a-narrative-review/
Update on tocilizumab in rheumatoid arthritis: a narrative review. - International Association for...
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by joint pain, swelling, and stiffness, affecting approximately 1% of the adult...
rheumatoid arthritisnarrative reviewinternational associationupdatetocilizumab
https://adisinsight.springer.com/drugsafety/803674295?error=cookies_not_supported&code=f861b3de-b2d4-4578-8274-6b44aa3cf39e
Tocilizumab - AdisInsight
An 83-year-old woman developed eosinophilic granulomatosis with polyangiitis during treatment with tocilizumab for rheumatoid arthritis (RA).The woman, who had
tocilizumab
https://pure.amsterdamumc.nl/en/publications/tocilizumab-monotherapy-versus-adalimumab-monotherapy-for-treatme-3/
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis...
rheumatoid arthritistocilizumabversusadalimumabtreatment
https://www.milanmedicals.com/product-tag/tocilizumab/
Tocilizumab - Milan Medicals
tocilizumabmilanmedicals
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2021.790547/full
Frontiers | Tocilizumab in the Treatment of Chronic Antibody-Mediated Rejection Post Kidney...
Introduction: Chronic antibody-mediated rejection (cAMR) has very few effective therapeutic options. Interleukin-6 is an attractive target because it is invo...
the treatmentfrontierstocilizumabchronicantibody
https://rheumatology.org/press-releases/american-college-of-rheumatology-update-on-tocilizumab-shortages
Press Release: ACR Update on Tocilizumab Shortages | American College of Rheumatology
The ACR is actively engaged with the FDA Center for Drug Evaluation and Research (CDER) drug shortage team as they work with the manufacturer to resolve...
press releaseamerican collegeacrupdatetocilizumab
https://www.mdpi.com/2077-0383/11/19/5559
Is Tocilizumab Plus Dexamethasone Associated with Superinfection in Critically Ill COVID-19...
Background: Dexamethasone and tocilizumab are used to treat severely ill COVID-19 patients admitted to intensive care units (ICUs). We explored whether...
associated withtocilizumabplusdexamethasonecritically
https://medicalresearch.com/covid-19-targeted-anti-inflammatory-tocilizumab-reduced-mortality-in-critically-ill-patients/
MedicalResearch.com | COVID-19: Targeted Anti-Inflammatory Tocilizumab Reduced Mortality in...
Our findings suggest that tocilizumab is a promising therapy to reduce mortality in critically ill patients with COVID-19, particularly in those with a rapid...
anti inflammatorymedicalresearchcovidtargetedtocilizumab
https://scholarlycommons.henryford.com/pulmonary_articles/167/
"Tocilizumab Associated With Survival in Patients Hospitalized for COVI" by Raef A. Fadel, Ashley...
BACKGROUND: Acute respiratory distress syndrome (ARDS) with oliguria is associated with increased mortality. Interleukin-6 (IL-6) plays an integral role in the...
associated within patientstocilizumabsurvivalhospitalized
https://www.goodwinlaw.com/en/insights/blogs/2022/01/ptab-institutes-two-iprs-on-tocilizumab-patents
PTAB Institutes Two IPRs on Tocilizumab Patents | Insights & Resources | Goodwin
ptabinstitutestwoiprstocilizumab
https://saydalia.ma/ar/composition/tocilizumab/
Tocilizumab - Saydalia
tocilizumab
https://scienceportal.tecnalia.com/en/publications/c-reactive-protein-cut-off-for-early-tocilizumab-and-dexamethason/
C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized...
cut offreactiveproteinearlytocilizumab
https://www.pharmawiki.ch/wiki/index.php?wiki=Tocilizumab
PharmaWiki - Tocilizumab
tocilizumab
https://www.ispor.org/vih-articles/Volume-19--Issue-3/TOCILIZUMAB-MONOTHERAPY-IN-PATIENTS-WHERE-METHOTREXATE-IS-CONSIDERED-INAPPROPRIATE--A-CANADIAN-COST-UTILITY-ANALYSIS
TOCILIZUMAB MONOTHERAPY IN PATIENTS WHERE METHOTREXATE IS CONSIDERED INAPPROPRIATE- A CANADIAN...
in patientstocilizumabmethotrexateconsideredinappropriate
https://tum300.de/wirkstoffe/tocilizumab?view=alphabetical
Tocilizumab | TUM300
tocilizumab
https://www.rheuma-online.de/medikamente/tocilizumab-roactemra/morbus-still/
Tocilizumab bei Patienten mit systemischer juveniler idiopathischer Arthritis (sJIA, Morbus Still)...
tocilizumabbeipatientenmitarthritis
https://synapse.patsnap.com/drug/ddc7b1d7b3474e9c975042600540ed2a
Tocilizumab biosimilar (Zhejiang Hisun) - Drug Targets, Indications, Patents - Synapse
drug targetstocilizumabbiosimilarzhejianghisun